The Journal of Antibiotics · 1999 · 42 citations · 6 references
Life SciencesBiochemistryPharmacologyEnzymologyMetabolismStructure-activity RelationshipsFatty Acid BiosynthesisFatty Acid MetabolismLipid BiosynthesisLipid Biosynthesis InhibitionLipid MetabolismTriglyceride MetabolismAcyltransferase ActivityAcyltransferase EnzymesDiacylglycerol AcyltransferaseDiacylglycerol MetabolismGlycerolipid BiosynthesisGlycerolipid MetabolismTriglyceride Biosynthesis Inhibition
The structures of roselipins 1A, 1B, 2A and 2B were elucidated by spectroscopic studies including 1H-1H COSY, 13C-1H COSY, 13C-1H HMQC and 13C-1H HMBC NMR experiments, and degradation experiments. They have the common skeleton of 2,4,6,8,10,12,14,16,18-nonamethyl-5,9,13-trihydroxy-2E,6E, 10E-icosenoic acid modified with a D-mannose and a D-arabinitol. Roselipin A and B groups were stereoisomers at the arabinitol moiety, which esterified the fatty acid from the different terminal hydroxy residue. Roselipin 2 group was 6"-O-acetyl roselipin 1 group.
6
T.G. Walker, Robert E. London, Thomas W. Whaley et al. · Journal of the American Chemical Society · 1976 · 182 citations
Pharmacy, Biochemistry, Chemistry +17